Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Covalon Technologies Ltd
V.COV
Alternate Symbol(s):
CVALF
Healthcare
Medical Instruments & Supplies
Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold...
under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:COV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
Next
(5)
•••
mcappro
X
Post by
mcappro
on Sep 11, 2021 9:04am
Earnings call transcript - COV/CVALF
https://seekingalpha.com/article/4452601-covalon-technologies-cvalf-ceo-brian-pedlar-on-q3-2021-results-earnings-call-transcript
(2269)
•••
Betteryear2
X
Post by
Betteryear2
on Aug 29, 2021 8:07pm
Conference Call to Discuss Third Quarter Fiscal 2021 Results
MISSISSAUGA, ON, Aug. 26, 2021 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company
...more
(4971)
•••
nozzpack
X
Post by
nozzpack
on Jul 30, 2021 8:24am
Aquaguard Revenues ?
Dont the Aquaguard Revenues make up about 50 % of total Revenues ? If so, this is a huge chunk of potential sales and earnings removed from whats left which looks to be in the $12 million range per
...more
(13)
•••
Sikong
X
Comment by
Sikong
on Jul 29, 2021 6:56pm
RE:V.Cov is a similar opportunity as v.pay
My hope has not come true. They sold just 1 product line, with quite a lot of gains though as compoared to the price they paid to buy AquaGuard. I'm not super satisfied, after almost half
...more
(13)
•••
Sikong
X
Comment by
Sikong
on Jul 29, 2021 6:45pm
RE:RE:Interesting
I believe there is still room for upsides. Waiting for the Q result. Previously they say they will be profitable this year. Middle east sales in last Q were also up significantly.
(313)
•••
mavericks2020
X
Comment by
mavericks2020
on Jul 29, 2021 3:42pm
RE:Interesting
i don t know if we have a gap next week. i think yes
(313)
•••
mavericks2020
X
Post by
mavericks2020
on Jul 29, 2021 11:00am
https://www.barchart.com/stocks/quotes/COV.VN/opinion
eom
(17)
•••
ARIMA11
X
Post by
ARIMA11
on Jul 29, 2021 10:18am
Interesting
https://ceo.ca/@newswire/covalon-announces-sale-of-its-aquaguard-product-line
(17)
•••
ARIMA11
X
Post by
ARIMA11
on Jul 29, 2021 8:52am
Halted...
Pending news...
Prev
1
2
3
4
5
6
7
8
9
10
11
12
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
New Analyst Report Lifts Almonty Target Price to CDN$5.50
Mullen Group acquires company expected to generate annualized revenues of $300 million
Despite turbulent markets this logistics company continues to grow